Cargando…

Triple Combination of Amantadine, Ribavirin, and Oseltamivir Is Highly Active and Synergistic against Drug Resistant Influenza Virus Strains In Vitro

The rapid emergence and subsequent spread of the novel 2009 Influenza A/H1N1 virus (2009 H1N1) has prompted the World Health Organization to declare the first pandemic of the 21(st) century, highlighting the threat of influenza to public health and healthcare systems. Widespread resistance to both c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nguyen, Jack T., Hoopes, Justin D., Le, Minh H., Smee, Donald F., Patick, Amy K., Faix, Dennis J., Blair, Patrick J., de Jong, Menno D., Prichard, Mark N., Went, Gregory T.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2825274/ https://www.ncbi.nlm.nih.gov/pubmed/20179772 http://dx.doi.org/10.1371/journal.pone.0009332

Ejemplares similares

Efficacy of Combined Therapy with Amantadine, Oseltamivir, and Ribavirin In Vivo against Susceptible and Amantadine-Resistant Influenza A Viruses
por: Nguyen, Jack T., et al.
Publicado: (2012)

Triple Combination Antiviral Drug (TCAD) Composed of Amantadine, Oseltamivir, and Ribavirin Impedes the Selection of Drug-Resistant Influenza A Virus
por: Hoopes, Justin D., et al.
Publicado: (2011)

Simultaneous Detection of Oseltamivir- and Amantadine-Resistant Influenza by Oligonucleotide Microarray Visualization
por: Zhang, Yingjie, et al.
Publicado: (2013)

Oseltamivir- and Amantadine-Resistant Influenza Virus A (H1N1)
por: Cheng, Peter K.C., et al.
Publicado: (2010)

Oseltamivir- and Amantadine-Resistant Influenza Viruses A (H1N1)
por: Cheng, Peter K.C., et al.
Publicado: (2009)

A Randomized, Crossover Study to Evaluate the Pharmacokinetics of Amantadine and Oseltamivir Administered Alone and in Combination
por: Morrison, Dennis, et al.
Publicado: (2007)

Treatment of Immunocompromised, Critically Ill Patients with Influenza A H1N1 Infection with a Combination of Oseltamivir, Amantadine, and Zanamivir
por: Meijer, Wouter J., et al.
Publicado: (2015)

Pharmacokinetics and Pharmacodynamics of Conventional-Dose vs Triple-Dose Oseltamivir in Severely Immunocompromised Children With Influenza
por: Bautista, Francisco, et al.
Publicado: (2019)

Oseltamivir in human avian influenza infection
por: Smith, James R.
Publicado: (2010)

Pharmacokinetics of ADS-5102 (Amantadine) Extended Release Capsules Administered Once Daily at Bedtime for the Treatment of Dyskinesia
por: Hauser, Robert A., et al.
Publicado: (2018)

Investigation of a recent rise of dual amantadine-resistance mutations in the influenza A M2 sequence
por: Durrant, Matthew G, et al.
Publicado: (2015)

Inhibition of Influenza Virus Replication by Oseltamivir Derivatives
por: Chan, Renee W. Y., et al.
Publicado: (2022)

Amantadine extended release for levodopa‐induced dyskinesia in Parkinson's disease (EASED Study)
por: Pahwa, Rajesh, et al.
Publicado: (2015)

Amantadine resistance among influenza A isolates in Sweden 2001–2006
por: Brytting, M., et al.
Publicado: (2006)

Efficacy comparison of oseltamivir alone and oseltamivir-antibiotic combination for early resolution of symptoms of severe influenza-A and influenza-B hospitalized patients
por: Ishaqui, Azfar A., et al.
Publicado: (2020)

Structure of the Amantadine Binding Site of Influenza M2 Proton Channels In Lipid Bilayers
por: Cady, Sarah D., et al.
Publicado: (2010)

Efficacy of oseltamivir treatment in influenza virus-infected obese mice
por: Honce, Rebekah, et al.
Publicado: (2023)

The Combined Effect of Oseltamivir and Favipiravir on Influenza A Virus Evolution
por: Ormond, Louise, et al.
Publicado: (2017)

Adherence to Oseltamivir Guidelines during Influenza Pandemic, the Netherlands
por: Fietjé, Esther H., et al.
Publicado: (2012)

Oseltamivir resistance in swine influenza: a brief discussion
por: Wiwanitkit, Viroj
Publicado: (2009)

Oseltamivir use amongst hospitalized patients infected with influenza
por: Herman, Michael, et al.
Publicado: (2014)

Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza
por: Hurt, Aeron C., et al.
Publicado: (2016)

Oseltamivir treatment of influenza A and B infections in infants
por: Mattila, Janna‐Maija, et al.
Publicado: (2021)

Evaluation of the Clinical Effectiveness of Oseltamivir for Influenza Treatment in Children
por: Qin, Jianru, et al.
Publicado: (2022)

Oseltamivir (Tamiflu(®)) in the environment, resistance development in influenza A viruses of dabbling ducks and the risk of transmission of an oseltamivir-resistant virus to humans – a review
por: Järhult, Josef D.
Publicado: (2012)

Amantadine Effect on Perceptions of Irritability after Traumatic Brain Injury: Results of the Amantadine Irritability Multisite Study
por: Hammond, Flora M., et al.
Publicado: (2015)

Widespread Oseltamivir Resistance in Influenza A Viruses (H1N1), South Africa
por: Besselaar, Terry G., et al.
Publicado: (2008)

Oseltamivir Is Adequately Absorbed Following Nasogastric Administration to Adult Patients with Severe H5N1 Influenza
por: Taylor, Walter R. J., et al.
Publicado: (2008)

Amantadine, COVID-19 and Parkinsonism
por: Wiwanitkit, Viroj
Publicado: (2020)

Comparison of efficacy and safety of oseltamivir and zanamivir in pandemic influenza treatment
por: Tuna, Nazan, et al.
Publicado: (2012)

1715 Oseltamivir use in an Influenza Outbreak: Linking Pharmacology to Pharmacoeconomics
por: Chaiyakunapruk, Nathorn, et al.
Publicado: (2014)

Effectiveness of Oseltamivir Prophylaxis in Influenza Outbreaks in Residential Aged Care
por: Dronavalli, Mithilesh, et al.
Publicado: (2020)

Maternal and Perinatal Outcomes of Influenza in Pregnancy after Treatment with Oseltamivir
por: Abraham, Kavitha, et al.
Publicado: (2021)

Interferon Lambda Delays the Emergence of Influenza Virus Resistance to Oseltamivir
por: Medaglia, Chiara, et al.
Publicado: (2021)

Lianhua-Qingwen Displays Antiviral and Anti-Inflammatory Activity and Synergistic Effects with Oseltamivir against Influenza B Virus Infection in the Mouse Model
por: Yang, Chunguang, et al.
Publicado: (2020)

Determination of the synergistic anti-influenza effect of Huangqin Su tablet and Oseltamivir and investigation of mechanism of the tablet based on gut microbiota and network pharmacology
por: Cui, Xuran, et al.
Publicado: (2023)

Sales of oseltamivir in Norway prior to the emergence of oseltamivir resistant influenza A(H1N1) viruses in 2007–08
por: Hauge, Siri H, et al.
Publicado: (2009)

Determination of clinical and demographic predictors of laboratory-confirmed influenza with subtype analysis
por: Woolpert, Tabitha, et al.
Publicado: (2012)

The Hypothiocyanite and Amantadine Combination Treatment Prevents Lethal Influenza A Virus Infection in Mice
por: Ashtiwi, Nuha Milad, et al.
Publicado: (2022)

Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy
por: Pradat, Pierre, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_s0h7ikrvc5bs42gbhvaoq34678